Sirorat Kobbuaklee

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Clonal hematopoietic mutations as a predictor of adverse outcomes in cytopenic patients with chronic kidney disease.

Clonal hematopoietic mutations as a predictor of adverse outcomes in cytopenic patients with chronic kidney disease.

Journal: Blood research

Published: May 04, 2026

Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG).

Laboratory Concordance and Prognostic Impact of 10-Color Flow Cytometry and Next-Generation Sequencing-Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B-Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group (TALWG).

Journal: International journal of laboratory hematology

Published: March 31, 2026

Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group.

Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group.

Journal: Journal of clinical laboratory analysis

Published: March 31, 2025

Prevalence and clinical outcomes of germline variants among patients with myeloid neoplasms.

Prevalence and clinical outcomes of germline variants among patients with myeloid neoplasms.

Journal: Journal of clinical pathology

Published: November 03, 2023

Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.

Good prognosis of adult hemophagocytic lymphohistiocytosis associated with the germline HAVCR2 mutation.

Journal: Experimental hematology

Published: June 30, 2023

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms.

Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 15, 2022

Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.

Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.

Journal: Haematologica

Published: November 14, 2022

Genetic mutations associated with blood count abnormalities in myeloid neoplasms.

Genetic mutations associated with blood count abnormalities in myeloid neoplasms.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 29, 2022

Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry.

Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry.

Journal: Hematology reports

Published: January 26, 2022

Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.

Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: September 29, 2021

Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.

Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 07, 2021

Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes.

Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: August 22, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026